News
Events
Blog
Contact
Ask the Experts
Board of Directors
Volunteers
Careers
What We Do
Integrated Programs
Turnkey solutions for shortening development times
Candidate Development
Selecting the right molecules for development
Early Development
Accelerating molecules through to proof-of-concept
Late Development
Accelerating products through to commercial manufacture
Tailored Services
Individual services to meet customer needs
Drug Substance
Route Scouting, PR&D, Small-Scale GMP Manufacture, DOE/QbD, Isotopic Labeling
Formulation Development
Dosage Forms, Pre-Formulation, Solubilization, Modified Release, Pediatrics
Clinical Trial Manufacturing
Phase I-III Clinical Supplies, Adaptive Manufacturing, High-Potency APIs
Commercial Manufacturing
Tech Transfer, Scale-Up, Registration, Process Validation
Clinical Pharmacology
First-in-Human, BA/BE, Human ADME, Pharmacy Compounding, Isotopic Labeling
Bioanalysis
Biotransformation, Quantitative Biological & Chemical Analysis, Insulin Analogues
Data Sciences
Data Management, Programming, Statistics/PK, Medical Writing
Drug Development Consulting
Scientific Advice, Developability Assessment, Program Design
About Quotient Sciences
At a Glance
We accelerate drug development. Saving precious time in getting medicines to patients.
Translational Pharmaceutics®
Our flagship platform for accelerating & optimizing drug product development.
Our Manifesto
We believe molecules need to become cures, fast. Because humanity needs solutions, fast.
Life at Quotient
Explore how team work is the key to our success
Science, Agility, Culture
Finding creative solutions, delivering for our customers.
Awards & Achievements
We have been recognized with various awards throughout the years. Take a look now.
Resources
Whitepaper
Accelerating the Development of Oncology Medicines
Oncology drugs dominate today’s research focus with over >5500 molecules in development, representing over 35% …
Whitepaper
Accelerating the Developing of Orphan Drugs for Rare Diseases
Worldwide there are over 300 million people living with identified rare diseases. This white paper …
Case Studies
Druggability Technologies Case Study
Druggability Technologies (DRGT) was developing DRGT-46 as a novel therapy for pain. Gabor Heltovics, the …
Resources
Case studies
Info sheets
Scientific posters
Testimonials
Whitepapers
Webinars
What We Do
Back
What We Do
Integrated Programs
Back
What We Do
Candidate Development
Early Development
Late Development
Tailored Services
Back
What We Do
Drug Substance
Formulation Development
Clinical Trial Manufacturing
Commercial Manufacturing
Clinical Pharmacology
Bioanalysis
Data Sciences
Drug Development Consulting
About Quotient Sciences
Back
About Quotient Sciences
At a Glance
Translational Pharmaceutics®
Our Manifesto
Life at Quotient
Science, Agility, Culture
Awards & Achievements
Resources
Back
Resources
Case studies
Info sheets
Scientific posters
Testimonials
Whitepapers
Webinars
Careers
Quick links
Back
News
Events
Blog
Contact
Ask the Experts
Board of Directors
Volunteers
Press enter to search
Suggested searches
Early Development
Candidate Selection
Late Development
ADME
Translational Pharmaceutics
Resources
Resource Centre
Resource type
Article
Case Studies
Info Sheet
Peer Reviewed Publication
Scientific Posters
Webinar
Whitepaper
Topic
Clinical Pharmacology
Modified Release
Bioanalysis
Real-time Manufacturing
Radiosynthesis
Pediatrics
Solubility Enhancement
Formulation Development
Human ADME
Isotope Labeling
Translational Pharmaceutics
Drug Substance
Materials Science
Modeling and Simulation
Commercial Manufacturing
Oncology
Gamma Scintigraphy
Drug Product
First-in-Human
Regulatory
High Potency Handling
Drug Product Optimization
Clinical Trial Manufacturing
Microbiology
Analytical Sciences
Quotient Sciences and Charles River Collaboration
Spray Drying
Reset filters
Filter
12
/ 92 resources
Scientific Posters
BPS 2022 Poster - A Phase 1 Randomized PK Study of Amilo-5MER
A Phase 1, Randomized, Double-Blind, PlaceboControlled, First-in-Human Study to Assess Safety, Tolerability & Pharmacokinetics (PK) of Amilo-5MER in Healthy Volunteers
Scientific Posters
Applications of Lipid-based Formulations and the Benefits of Integrating Manufacturing and Clinical Testing in Formulation Selection
The purpose of this study is to analyze pharmaceutical and clinical data from multiple development programs to understand the drivers and outcomes of selecting and dosing different lipid formulations.
Scientific Posters
Why Archiving is a Crucial Part of Any Clinical Trial
A Quotient Sciences Poster by Erika Reategui, Director, GCP Quality Assurance, Quality Assurance: Why Archiving is a Crucial Part of Any Clinical Trial
Scientific Posters
An integrated radiolabelled study to determine the mass balance, metabolite profile and identification, and absolute bioavailability of nolasiban in healthy female subjects
Quotient Sciences Poster : An Integrated Radiolabelled Study to Determine the Mass Balance, Metabolite Profile and Identification and Absolute Bioavailability of Nolasiban in Healthy Female Subjects
Scientific Posters
Influence of drug loading and fillers on drug release from HPMC matrix tablets
Quotient Sciences' Poster: Influence of drug loading and fillers on drug release from HPMC matrix tablets
Scientific Posters
Development of modified release matrix tablet formulation using solid lipid Compritol 888 for a poorly water soluble drug
Quotient Sciences Poster: Development of modified release matrix tablet formulation using solid lipid Compritol 888 for a poorly water soluble drug
Scientific Posters
Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Quotient Sciences EBF 2021 Poster: Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Scientific Posters
EBF 2021- Novel Copper Protein Speciation Method for Calculating Serum Non Ceruloplasmin Copper: A Comparative Analysis
Download our poster from the EBF 2021 conference entitled: Novel Copper Protein Speciation Method for Calculating Serum Non Ceruloplasmin Copper: A Comparative Analysis
Scientific Posters
EBF 2021- Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Download our poster from the EBF 2021 conference entitled: Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Scientific Posters
Pharmaceutical and clinical performance comparisons of modified release multiparticulates and matrix tablet formulations
Access our latest poster from AAPS 2021- Pharmaceutical and clinical performance comparisons of modified release multiparticulates and matrix tablet formulations. The purpose of this study is to review practical experiences of head to head pharmaceutical and clinical comparisons of MUPs and matrix tablet platforms to identify an optimal MR formulation.
Scientific Posters
Development and Application of a PBPK Model Using Theoretical Particle Size Distribution to Describe in vivo D issolution to Predict the Impact of Formulation Changes on Oral Bioavailability of GB001
Download our AAPS 2021 poster entitled: Development and Application of a PBPK Model Using Theoretical Particle Size Distribution to Describe in vivo D issolution to Predict the Impact of Formulation Changes on Oral Bioavailability of GB001
Scientific Posters
EuPFI 2021 - Taste Assessment Study of Belumosudil to Inform an Integrated Paediatric Formulation Development Program
Presented at the annual EuPFI event, this poster documents the project of Belumosudil, a ROCK2 selective inhibitor, is currently in development for the treatment of immune disorders.